Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
FINDARECALL QUICK READ
What this record tells you
This CPSC record concerns Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning and names Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream) as the recalling firm. Use the source fields below to narrow the match, then verify the exact item and current remedy on the issuing-agency page.
- Firm: Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)
- Classification: The recalled prescription drugs and products that
- Status: Ongoing
- Recall date: 2023-03-09
Compare model, item/style number, serial range, manufacturing date, importer, retailer, color, and other physical identifiers listed in the notice.
A CPSC photograph may show only one variation, so use the model/serial information and remedy instructions as the stronger match.
Product Description & Identification
This recall involves prescription drugs Aprepitant 125 mg capsules sold in cartons containing one blister card of 6 capsules and 5 gram tubes of Lidocaine and Prilocaine cream sold in cartons containing 5 tubes and packed with or without 12 dressings. The Aprepitant capsules are in a non-child resistant blister card packaged in a carton that has the name "Sandoz," the name of the medication, dosage, NDC number, lot number, and expiration date on the carton and on the blister cards. The warnings "This unit-dose packaging is not child-resistant" and "For institutional use only" are listed on the carton. The Lidocaine and Prilocaine cream is packaged in a 5 gram tube with a continuous thread white closure. The name "fougera®," the name of the medication, dosage and NDC number are printed on the carton and tube and the expiration date and lot number are printed on the carton and stamped on the crimp of the tube. The warning "FOR HOSPITAL USE ONLY" is printed on the carton and the tube. Product Description NDC Number Lot Number Expiration Date Aprepitant Capsules 125 mg 0781-2323-68 Carton of 1 Blister Pack of 6 capsules 0781-2323-06 Blister Pack LK3209 LC6454 04/2024 12/2023 Lidocaine and Prilocaine 2.5%/2.5% Cream 5 gram Tubes 0168-0357-56 Carton of 5 tubes and 12 dressings 0168-0357-55 Carton of 5 tubes 0168-0357-05 Tube LA2782 LA2784 LV0667 LX5350 MA1640 MB3205 LA2785 LR9041 MB3209 03/2023 03/2023 02/2024 03/2024 03/2024 04/2024 03/2023 11/2023 04/2024
Reason for Recall / Hazard Identified
Hazard: The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.. This recall involves prescription drugs Aprepitant 125 mg capsules sold in cartons containing one blister card of 6 capsules and 5 gram tubes of Lidocaine and Prilocaine cream sold in cartons containing 5 tubes and packed with or without 12 dressings. The Aprepitant capsules are in a non-child resistant blister card packaged in a carton that has the name "Sandoz," the name of the medication, dosage, NDC number, lot number, and expiration date on the carton and on the blister cards. The warnings "This unit-dose packaging is not child-resistant" and "For institutional use only" are listed on the carton. The Lidocaine and Prilocaine cream is packaged in a 5 gram tube with a continuous thread white closure. The name "fougera®," the name of the medication, dosage and NDC number are printed on the carton and tube and the expiration date and lot number are printed on the carton and stamped on the crimp of the tube. The warning "FOR HOSPITAL USE ONLY" is printed on the carton and the tube. Product Description NDC Number Lot Number Expiration Date Aprepitant Capsules 125 mg 0781-2323-68 Carton of 1 Blister Pack of 6 capsules 0781-2323-06 Blister Pack LK3209 LC6454 04/2024 12/2023 Lidocaine and Prilocaine 2.5%/2.5% Cream 5 gram Tubes 0168-0357-56 Carton of 5 tubes and 12 dressings 0168-0357-55 Carton of 5 tubes 0168-0357-05 Tube LA2782 LA2784 LV0667 LX5350 MA1640 MB3205 LA2785 LR9041 MB3209 03/2023 03/2023 02/2024 03/2024 03/2024 04/2024 03/2023 11/2023 04/2024
How to Check Whether Your Product Matches
A matching product name or photograph is not enough by itself. Compare every identifier available on your item or packaging with the official notice.
- Confirm the full product and brand or recalling-firm name.
- Compare package size, color, flavor, model, style, or configuration when listed.
- Check UPC, lot, batch, serial, date code, recall number, or USDA establishment number.
- Review the recall date and distribution information without assuming every seller is listed.
- Open the official CPSC source below and follow its current instructions.
If a required identifier is missing, contact the recalling company or issuing agency through the official notice rather than guessing.
Consumer Action Recorded in the Source
Distribution & Affected States
Nationwide retail and online distribution
Source-Provided Product Images
Image limitation: An image may show only one package, color, size, or model. Do not use a photograph alone to decide whether your product is affected.
Verify With the Issuing Agency
This record was last updated in our index on 2026-07-27 11:37:09 UTC. Because recall enforcement statuses and instructions evolve, always verify details directly with the issuing government agency.
Open CPSC Source Record →Record Transparency
- Issuing agency
- CPSC
- Source ID
- 9556
- Indexed update
- 2026-07-27 11:37:09 UTC
- Official source
- Open issuing-agency record